Next Article in Journal
Aliskiren: Just a New Drug for Few Selected Patients or an Innovative Molecule Predestinated to Replace Arbs and Ace-Inhibitors?
Next Article in Special Issue
Real Time Imaging of Biomarkers in the Parkinson's Brain Using Mini-Implantable Biosensors. II. Pharmaceutical Therapy with Bromocriptine
Previous Article in Journal
Obsessive-Compulsive and Post Traumatic Avoidance Symptoms Influence the Response to Antihypertensive Therapy: Relevance in Uncontrolled Hypertension
Pharmaceuticals 2009, 2(3), 94-117; doi:10.3390/ph2030094
Review

Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene

Received: 27 October 2009; in revised form: 10 November 2009 / Accepted: 19 November 2009 / Published: 20 November 2009
(This article belongs to the Special Issue Biomarkers)
View Full-Text   |   Download PDF [349 KB, uploaded 20 November 2009]   |   Browse Figures
Abstract: In the past several years a number of alterations in the PAFAH/PLA2G7/LpPLA2 gene have been described. These include inactivating mutations, polymorphisms in the coding region, and other genetic changes located in promoter and intronic regions of the gene. The consequences associated with these genetic variations have been evaluated from different perspectives, including in vitro biochemical and molecular studies and clinical analyses in human subjects. This review highlights the current state of the field and suggests new approaches that can be used to evaluate functional consequences associated with mutations and polymorphisms in the PAF-AH gene.
Keywords: PAF acetylhydrolase; PLA2G7; single nucleotide polymorphism; mutation; vascular disease PAF acetylhydrolase; PLA2G7; single nucleotide polymorphism; mutation; vascular disease
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Stafforini, D.M. Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene. Pharmaceuticals 2009, 2, 94-117.

AMA Style

Stafforini DM. Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene. Pharmaceuticals. 2009; 2(3):94-117.

Chicago/Turabian Style

Stafforini, Diana M. 2009. "Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene." Pharmaceuticals 2, no. 3: 94-117.


Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert